ResearcherXijing HospitalNo recent work listed

Yinghui Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5111-5348; OpenAlex author ID A5066434843. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper

Papers 1

CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2020.05.005 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhi‐Nan Chen · 1 shared paper, 2020 · strength 0.12
- Paper CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancre… DOI 10.1016/j.bbrc.2020.05.005 ↗
Jian‐Li Jiang · 1 shared paper, 2020 · strength 0.12
- Paper CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancre… DOI 10.1016/j.bbrc.2020.05.005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.